FreeCME

Update on Treatment Options for Leukemia

Jointly provided by CancerNet, A. Webb Roberts Center for CME of Baylor Scott & White Health and Amedco.

Grantor: Amgen, Inc., Janssen Scientific Affairs, LLC, Gilead Sciences Inc., Novartis Pharmaceuticals Corporation, Takeda Oncology, Pfizer.

Specialty: Hematology, Oncology

Statement of Need/Program Overview: This webcast is intended to improve care of patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia and chronic myeloid leukemia by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Target Audience: This webcast is designed to meet the educational needs of hematologists/oncologists, nurse practitioners, physician assistants, nurses and other health care professionals who diagnose, treat, and manage patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia and chronic myeloid leukemia.

This series consists of four CME activities. The links below will direct learners to activity details and content.